These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10325583)

  • 41. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects.
    Mathes C; Melero A; Conrad P; Vogt T; Rigo L; Selzer D; Prado WA; De Rossi C; Garrigues TM; Hansen S; Guterres SS; Pohlmann AR; Beck RCR; Lehr CM; Schaefer UF
    J Control Release; 2016 Feb; 223():207-214. PubMed ID: 26686081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
    Lavker RM; Kaidbey K; Leyden JJ
    J Am Acad Dermatol; 1992 Apr; 26(4):535-44. PubMed ID: 1597538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
    Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
    Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deposits from Creams Containing 20% (w/w) Urea and Suppression of Crystallization (Part 2): Novel Analytical Methods of Urea Accumulated in the Stratum Corneum by Tape stripping and Colorimetry.
    Goto N; Morita Y; Terada K
    Chem Pharm Bull (Tokyo); 2016; 64(8):1092-8. PubMed ID: 27477646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the vehicle on the amount of stratum corneum removed by tape stripping.
    Jacobi U; Meykadeh N; Sterry W; Lademann J
    J Dtsch Dermatol Ges; 2003 Nov; 1(11):884-9. PubMed ID: 16281579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
    Uliasz A; Zeichner J; Soung J; Wong V; Lebwohl M
    Cutis; 2008 Jun; 81(6):517-9. PubMed ID: 18666395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations.
    Harding SM; Sohail S; Busse MJ
    Clin Exp Dermatol; 1985 Jan; 10(1):13-21. PubMed ID: 3987081
    [No Abstract]   [Full Text] [Related]  

  • 52. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
    Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
    J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis.
    Røpke MA; Alonso C; Jung S; Norsgaard H; Richter C; Darvin ME; Litman T; Vogt A; Lademann J; Blume-Peytavi U; Kottner J
    J Dermatol Sci; 2017 Dec; 88(3):330-338. PubMed ID: 28911799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2004 Feb; 93(2):470-87. PubMed ID: 14705203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution.
    Bodenlenz M; Dragatin C; Liebenberger L; Tschapeller B; Boulgaropoulos B; Augustin T; Raml R; Gatschelhofer C; Wagner N; Benkali K; Rony F; Pieber T; Sinner F
    Pharm Res; 2016 Sep; 33(9):2229-38. PubMed ID: 27271272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration.
    Susilo R; Korting HC; Strauss UP; Menke G; Schuster O; Menke A
    Arzneimittelforschung; 2005; 55(6):338-42. PubMed ID: 16032974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eumovate (clobetasone butyrate) 0.05% cream with its moisturizing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis.
    Parneix-Spake A; Goustas P; Green R
    J Dermatolog Treat; 2001 Dec; 12(4):191-7. PubMed ID: 12241627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.